Help Us Study a New Treatment Option for OCD
Would you like to take part in a clinical trial for a new investigational medication for people suffering with OCD?
Why Join Us
We need your help in our mission to successfully develop the first new medication for OCD since the mid-1990s.
You will receive study-related care and evaluations of your OCD-related symptoms at no cost to you (no insurance required).
You may receive compensation for time and travel to attend study visits.
The Process to See If You Qualify
Enter your information in the form below.
Choose the date and time that works best for our care team to give you a call.
We’ll call you at your scheduled time to discuss your eligibility, options and next steps.
Please fill out the form and schedule a time for our care team to contact you about this clinical trial.
Biohaven Pharmaceuticals in New Haven, Connecticut, is the sponsor of the study. Biohaven researches a range of neurological and neurobiological disorders, and obsessive-compulsive disorder is an important focus of their work.
NOCD is a digital behavioral health company focused on identifying and treating OCD. NOCD is partnering with Biohaven to develop the first new medication for OCD since 1997.